Cite

HARVARD Citation

    Flores, E. et al. (2020). Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication. Journal for immunotherapy of cancer. 8 (1), p. . [Online]. 
  
Back to record